NM3086

N/A

Report date: 2023/06/07 16:05:11

Base Information

Drug NameNM3086
Drug Alias NameNM3086NM-3086
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionComplement C3 inhibitorsComplement C5 inhibitors
TargetsComplement C3Complement C5
Therapy Area/IndicationsHemoglobinuria, Paroxysmal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovelMed Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovelMed Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHemoglobinuria, Paroxysmal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A